As the coronavirus crisis drags on, As the coronavirus crisis drags on. Latest argument, Latest argument. Cette fake news, relayed by health institutions, runs counter to what has been learned in immunological science so far!

Latest argument, Latest argument. You will also discover other information that the media will not reveal to you. : immunity to covid was probably already reached in 50 % of the population even before the appearance of Sars-Cov-2!

Latest argument, Latest argument.

Latest argument New Health, Latest argument 2021 Par Pryska Ducoeurjoly

Latest argument, Latest argument ? From WHO to various health experts, From WHO to various health experts. From WHO to various health experts.

Could covid be an exception to the rule of the superiority of natural immunity? ?

Could covid be an exception to the rule of the superiority of natural immunity?… Could covid be an exception to the rule of the superiority of natural immunity?! Could covid be an exception to the rule of the superiority of natural immunity?¹ Could covid be an exception to the rule of the superiority of natural immunity?, Could covid be an exception to the rule of the superiority of natural immunity?² : Could covid be an exception to the rule of the superiority of natural immunity?, Could covid be an exception to the rule of the superiority of natural immunity?, Could covid be an exception to the rule of the superiority of natural immunity?  Could covid be an exception to the rule of the superiority of natural immunity?, Could covid be an exception to the rule of the superiority of natural immunity?

Could covid be an exception to the rule of the superiority of natural immunity?! You claim to impose your point of view authoritatively on millions of Americans! ». You claim to impose your point of view authoritatively on millions of Americans 30 septembre 2021, You claim to impose your point of view authoritatively on millions of Americans³, You claim to impose your point of view authoritatively on millions of Americans : You claim to impose your point of view authoritatively on millions of Americans : You claim to impose your point of view authoritatively on millions of Americans, You claim to impose your point of view authoritatively on millions of Americans. »

You claim to impose your point of view authoritatively on millions of Americans, You claim to impose your point of view authoritatively on millions of Americans⁴. You claim to impose your point of view authoritatively on millions of Americans⁵ : You claim to impose your point of view authoritatively on millions of Americans 1% You claim to impose your point of view authoritatively on millions of Americans. You claim to impose your point of view authoritatively on millions of Americans.

The vaccinated, The vaccinated ?

The vaccinated 1% The vaccinated, actually, The vaccinated! The vaccinated, The vaccinated, The vaccinated⁶ The vaccinated.⁷ The vaccinated, The vaccinated, The vaccinated. The vaccinated The vaccinated⁸ The vaccinated : “the vast majority of these reinfections are not strictly speaking reinfections since they are asymptomatic⁹ : “the vast majority of these reinfections are not strictly speaking reinfections since they are asymptomatic. “the vast majority of these reinfections are not strictly speaking reinfections since they are asymptomatic ; “the vast majority of these reinfections are not strictly speaking reinfections since they are asymptomatic. “the vast majority of these reinfections are not strictly speaking reinfections since they are asymptomatic, “the vast majority of these reinfections are not strictly speaking reinfections since they are asymptomatic. “the vast majority of these reinfections are not strictly speaking reinfections since they are asymptomatic, “the vast majority of these reinfections are not strictly speaking reinfections since they are asymptomatic?

“the vast majority of these reinfections are not strictly speaking reinfections since they are asymptomatic :

– Vaccinated people are at higher risk of COVID-19 hospitalizations (6,7 Vaccinated people are at higher risk of COVID-19 hospitalizations) Vaccinated people are at higher risk of COVID-19 hospitalizations. Vaccinated people are at higher risk of COVID-19 hospitalizations 27 Vaccinated people are at higher risk of COVID-19 hospitalizations, Vaccinated people are at higher risk of COVID-19 hospitalizations (Vaccinated people are at higher risk of COVID-19 hospitalizations, August 2021, Vaccinated people are at higher risk of COVID-19 hospitalizations.¹⁰ on 700.000 Vaccinated people are at higher risk of COVID-19 hospitalizations).

– Vaccinated people are at higher risk of COVID-19 hospitalizations 84 % Vaccinated people are at higher risk of COVID-19 hospitalizations 93 % Vaccinated people are at higher risk of COVID-19 hospitalizations, Vaccinated people are at higher risk of COVID-19 hospitalizations¹¹ Vaccinated people are at higher risk of COVID-19 hospitalizations 2021, Vaccinated people are at higher risk of COVID-19 hospitalizations 25 661 Vaccinated people are at higher risk of COVID-19 hospitalizations (Vaccinated people are at higher risk of COVID-19 hospitalizations). The rest of this study also showed the superiority of natural immunity against the Delta variant.

The rest of this study also showed the superiority of natural immunity against the Delta variant

 The rest of this study also showed the superiority of natural immunity against the Delta variant 2020, The rest of this study also showed the superiority of natural immunity against the Delta variant, The rest of this study also showed the superiority of natural immunity against the Delta variant, The rest of this study also showed the superiority of natural immunity against the Delta variant, The rest of this study also showed the superiority of natural immunity against the Delta variant. The rest of this study also showed the superiority of natural immunity against the Delta variant 13 November 2020, The rest of this study also showed the superiority of natural immunity against the Delta variant ! The rest of this study also showed the superiority of natural immunity against the Delta variant 31 December 2020 The rest of this study also showed the superiority of natural immunity against the Delta variant, while recognizing that we do not know the threshold of vaccination coverage to be obtained to achieve this collective immunity. »

while recognizing that we do not know the threshold of vaccination coverage to be obtained to achieve this collective immunity. » (while recognizing that we do not know the threshold of vaccination coverage to be obtained to achieve this collective immunity. »). Recently, while recognizing that we do not know the threshold of vaccination coverage to be obtained to achieve this collective immunity. », while recognizing that we do not know the threshold of vaccination coverage to be obtained to achieve this collective immunity. »: while recognizing that we do not know the threshold of vaccination coverage to be obtained to achieve this collective immunity. », while recognizing that we do not know the threshold of vaccination coverage to be obtained to achieve this collective immunity. ». Autrement dit : while recognizing that we do not know the threshold of vaccination coverage to be obtained to achieve this collective immunity. » (while recognizing that we do not know the threshold of vaccination coverage to be obtained to achieve this collective immunity. ») n’auraient plus la même valeur selon que vous avez été vacciné ou, on the contrary, infecté de manière naturelle…

Les anticorps arrangent ou… dérangent

Les autorités sanitaires ne sont pas à un paradoxe près. Elles bénissent les anticorps dès lors qu’ils sont invoqués comme marqueurs de l’efficacité vaccinale, notamment dans les études cliniques. À l’inverse, elles minimisent leur valeur dans un contexte d’immunisation naturelle. Cette incohérence est lisible dans la politique sanitaire :

– d’un côté, le passe-sanitaire recale les anticorps comme marqueur de l’immunité.  « Selon le ministère de la Santé, the state of scientific knowledge does not make it possible to determine for how long the presence of antibodies protects against new contamination.¹², the state of scientific knowledge does not make it possible to determine for how long the presence of antibodies protects against new contamination.. That is why, the state of scientific knowledge does not make it possible to determine for how long the presence of antibodies protects against new contamination. (HAS), the state of scientific knowledge does not make it possible to determine for how long the presence of antibodies protects against new contamination., the state of scientific knowledge does not make it possible to determine for how long the presence of antibodies protects against new contamination. (the state of scientific knowledge does not make it possible to determine for how long the presence of antibodies protects against new contamination.) the state of scientific knowledge does not make it possible to determine for how long the presence of antibodies protects against new contamination.. the state of scientific knowledge does not make it possible to determine for how long the presence of antibodies protects against new contamination., the state of scientific knowledge does not make it possible to determine for how long the presence of antibodies protects against new contamination.. Otherwise, the state of scientific knowledge does not make it possible to determine for how long the presence of antibodies protects against new contamination. (the state of scientific knowledge does not make it possible to determine for how long the presence of antibodies protects against new contamination.) the state of scientific knowledge does not make it possible to determine for how long the presence of antibodies protects against new contamination.. the state of scientific knowledge does not make it possible to determine for how long the presence of antibodies protects against new contamination.?

– the state of scientific knowledge does not make it possible to determine for how long the presence of antibodies protects against new contamination., antibodies are recognized as a marker of efficacy for all vaccines in clinical studies. antibodies are recognized as a marker of efficacy for all vaccines in clinical studies 2 (antibodies are recognized as a marker of efficacy for all vaccines in clinical studies, antibodies are recognized as a marker of efficacy for all vaccines in clinical studies, antibodies are recognized as a marker of efficacy for all vaccines in clinical studies¹³). antibodies are recognized as a marker of efficacy for all vaccines in clinical studies : antibodies are recognized as a marker of efficacy for all vaccines in clinical studies antibodies are recognized as a marker of efficacy for all vaccines in clinical studies 6 antibodies are recognized as a marker of efficacy for all vaccines in clinical studies 18 to 55 years¹⁴ ». antibodies are recognized as a marker of efficacy for all vaccines in clinical studies, antibodies are recognized as a marker of efficacy for all vaccines in clinical studies!

Update 23/08/22 : De forts taux d’anticorps sont corrélés à des effets secondaires accrus après une vaccination : Wataru Takahashi et al., “Association of Systemic Adverse Reactions and Serum SARS-CoV-2 Spike Protein Antibody Levels after Administration of BNT162b2 mRNA COVID-19 Vaccine“, Internal Medicine.

The role of antibodies overestimated

As a matter of fact, The role of antibodies overestimated. The role of antibodies overestimated, The role of antibodies overestimated.

The role of antibodies overestimated 60, The role of antibodies overestimated, The role of antibodies overestimated, However, The role of antibodies overestimated, The role of antibodies overestimated The role of antibodies overestimated, The role of antibodies overestimated.¹⁵ The role of antibodies overestimated, he noted that a mid-20th century British survey of the relationship between the incidence of diphtheria and the presence of antibodies concluded that there was no observable correlation between the number of antibodies and the incidence disease". he noted that a mid-20th century British survey of the relationship between the incidence of diphtheria and the presence of antibodies concluded that there was no observable correlation between the number of antibodies and the incidence disease". he noted that a mid-20th century British survey of the relationship between the incidence of diphtheria and the presence of antibodies concluded that there was no observable correlation between the number of antibodies and the incidence disease", he noted that a mid-20th century British survey of the relationship between the incidence of diphtheria and the presence of antibodies concluded that there was no observable correlation between the number of antibodies and the incidence disease". he noted that a mid-20th century British survey of the relationship between the incidence of diphtheria and the presence of antibodies concluded that there was no observable correlation between the number of antibodies and the incidence disease", so they can be misleading.

so they can be misleading, so they can be misleading, so they can be misleading? so they can be misleading¹⁶ so they can be misleading ? On the one hand, so they can be misleading, so they can be misleading. On the other hand, so they can be misleading, so they can be misleading (so they can be misleading)¹⁷) so they can be misleading.

so they can be misleading (so they can be misleading) to 35 (so they can be misleading) without symptoms cannot be defined as a reinfection”, without symptoms cannot be defined as a reinfection”. without symptoms cannot be defined as a reinfection”.

without symptoms cannot be defined as a reinfection”

without symptoms cannot be defined as a reinfection”, without symptoms cannot be defined as a reinfection”. In without symptoms cannot be defined as a reinfection” 2021 without symptoms cannot be defined as a reinfection”, without symptoms cannot be defined as a reinfection” : serology, without symptoms cannot be defined as a reinfection”, without symptoms cannot be defined as a reinfection”. On the one hand, without symptoms cannot be defined as a reinfection”, some tests are far from meeting the sensitivity and effectiveness criteria proposed by the FDA”. On the other hand, some tests are far from meeting the sensitivity and effectiveness criteria proposed by the FDA” 2019. « Depuis, some tests are far from meeting the sensitivity and effectiveness criteria proposed by the FDA”. some tests are far from meeting the sensitivity and effectiveness criteria proposed by the FDA”.

As a matter of fact, 50% some tests are far from meeting the sensitivity and effectiveness criteria proposed by the FDA”,¹⁸ some tests are far from meeting the sensitivity and effectiveness criteria proposed by the FDA” (rhumes). This is what we discover when other markers enter into the analysis., This is what we discover when other markers enter into the analysis.. This is what we discover when other markers enter into the analysis., This is what we discover when other markers enter into the analysis..

This is what we discover when other markers enter into the analysis. : This is what we discover when other markers enter into the analysis.?

This is what we discover when other markers enter into the analysis.. This is what we discover when other markers enter into the analysis. :

• d’un côté, This is what we discover when other markers enter into the analysis., This is what we discover when other markers enter into the analysis., This is what we discover when other markers enter into the analysis.¹⁹ (This is what we discover when other markers enter into the analysis., This is what we discover when other markers enter into the analysis., This is what we discover when other markers enter into the analysis.) ;
• This is what we discover when other markers enter into the analysis., This is what we discover when other markers enter into the analysis., This is what we discover when other markers enter into the analysis.. This acquired immunity will neutralize everything that has passed to the internal environment thanks to the B and T lymphocytes, This acquired immunity will neutralize everything that has passed to the internal environment thanks to the B and T lymphocytes. This acquired immunity will neutralize everything that has passed to the internal environment thanks to the B and T lymphocytes, This acquired immunity will neutralize everything that has passed to the internal environment thanks to the B and T lymphocytes.

This acquired immunity will neutralize everything that has passed to the internal environment thanks to the B and T lymphocytes, This acquired immunity will neutralize everything that has passed to the internal environment thanks to the B and T lymphocytes.

This acquired immunity will neutralize everything that has passed to the internal environment thanks to the B and T lymphocytes? It is difficult to assess innate immunity, in particular because it is complex to isolate, It is difficult to assess innate immunity, in particular because it is complex to isolate, It is difficult to assess innate immunity, in particular because it is complex to isolate :

– It is difficult to assess innate immunity, in particular because it is complex to isolate, It is difficult to assess innate immunity, in particular because it is complex to isolate.

– It is difficult to assess innate immunity, in particular because it is complex to isolate (serology).

It is difficult to assess innate immunity, in particular because it is complex to isolate, possible!

It is difficult to assess innate immunity, in particular because it is complex to isolate,²⁰ It is difficult to assess innate immunity, in particular because it is complex to isolate : It is difficult to assess innate immunity, in particular because it is complex to isolate.

It is difficult to assess innate immunity, in particular because it is complex to isolate, It is difficult to assess innate immunity, in particular because it is complex to isolate, may not have measurable antibodies. Par conséquent, may not have measurable antibodies. Au contraire, may not have measurable antibodies, may not have measurable antibodies.

may not have measurable antibodies 2020 (may not have measurable antibodies), may not have measurable antibodies²¹, may not have measurable antibodies.

may not have measurable antibodies, may not have measurable antibodies :

– may not have measurable antibodies. The cellular response, The cellular response, The cellular response, The cellular response 2020.²²

– The cellular response (The cellular response) The cellular response, The cellular response (The cellular response, ed). The cellular response, The cellular response.²³

The cellular response, The cellular response 2. She also knows that "the persistence of antibodies or cytotoxic effector cells is not the only indicator of the existence of an immunity that can be protective".²⁴  

She also knows that "the persistence of antibodies or cytotoxic effector cells is not the only indicator of the existence of an immunity that can be protective". She also knows that "the persistence of antibodies or cytotoxic effector cells is not the only indicator of the existence of an immunity that can be protective" She also knows that "the persistence of antibodies or cytotoxic effector cells is not the only indicator of the existence of an immunity that can be protective"

She also knows that "the persistence of antibodies or cytotoxic effector cells is not the only indicator of the existence of an immunity that can be protective", She also knows that "the persistence of antibodies or cytotoxic effector cells is not the only indicator of the existence of an immunity that can be protective" : “T cell-based diagnostics may have advantages over serological tests, “T cell-based diagnostics may have advantages over serological tests²⁵ », “T cell-based diagnostics may have advantages over serological tests.

“T cell-based diagnostics may have advantages over serological tests, “T cell-based diagnostics may have advantages over serological tests

“T cell-based diagnostics may have advantages over serological tests, “T cell-based diagnostics may have advantages over serological tests : “T cell-based diagnostics may have advantages over serological tests : “T cell-based diagnostics may have advantages over serological tests (“T cell-based diagnostics may have advantages over serological tests) “T cell-based diagnostics may have advantages over serological tests, “T cell-based diagnostics may have advantages over serological tests. “T cell-based diagnostics may have advantages over serological tests (“T cell-based diagnostics may have advantages over serological tests (“T cell-based diagnostics may have advantages over serological tests) “T cell-based diagnostics may have advantages over serological tests) measures the specific cellular response to more than 250 measures the specific cellular response to more than (S) measures the specific cellular response to more than (N) measures the specific cellular response to more than. measures the specific cellular response to more than, after 20 measures the specific cellular response to more than, measures the specific cellular response to more than. measures the specific cellular response to more than (measures the specific cellular response to more than) measures the specific cellular response to more than (measures the specific cellular response to more than) ».

measures the specific cellular response to more than

measures the specific cellular response to more thanCovid-19, measures the specific cellular response to more than »,²⁶ Hélène Banoun gives the result of the match from studies that include a larger set of biological markers: 

– Hélène Banoun gives the result of the match from studies that include a larger set of biological markers, Hélène Banoun gives the result of the match from studies that include a larger set of biological markers.

– Hélène Banoun gives the result of the match from studies that include a larger set of biological markers 18 Hélène Banoun gives the result of the match from studies that include a larger set of biological markers (Hélène Banoun gives the result of the match from studies that include a larger set of biological markers) Hélène Banoun gives the result of the match from studies that include a larger set of biological markers, Hélène Banoun gives the result of the match from studies that include a larger set of biological markers, Hélène Banoun gives the result of the match from studies that include a larger set of biological markers “Studies of individuals recovered from COVID-19 have detected SARS-CoV-2-specific T cells nine months after infection, “Studies of individuals recovered from COVID-19 have detected SARS-CoV-2-specific T cells nine months after infection, “Studies of individuals recovered from COVID-19 have detected SARS-CoV-2-specific T cells nine months after infection.²⁷ 

– “Studies of individuals recovered from COVID-19 have detected SARS-CoV-2-specific T cells nine months after infection 21 septembre 2021 “Studies of individuals recovered from COVID-19 have detected SARS-CoV-2-specific T cells nine months after infection (antibody) “Studies of individuals recovered from COVID-19 have detected SARS-CoV-2-specific T cells nine months after infection 14 month, “Studies of individuals recovered from COVID-19 have detected SARS-CoV-2-specific T cells nine months after infection : “Studies of individuals recovered from COVID-19 have detected SARS-CoV-2-specific T cells nine months after infection, “Studies of individuals recovered from COVID-19 have detected SARS-CoV-2-specific T cells nine months after infection, “Studies of individuals recovered from COVID-19 have detected SARS-CoV-2-specific T cells nine months after infection. “Studies of individuals recovered from COVID-19 have detected SARS-CoV-2-specific T cells nine months after infection, “Studies of individuals recovered from COVID-19 have detected SARS-CoV-2-specific T cells nine months after infection, could affect the immune system's ability to maintain sufficient levels of long-lived plasma cells that support the continuity of the antibody reservoir over time.".²⁸

In conclusion, could affect the immune system's ability to maintain sufficient levels of long-lived plasma cells that support the continuity of the antibody reservoir over time.".

could affect the immune system's ability to maintain sufficient levels of long-lived plasma cells that support the continuity of the antibody reservoir over time."

could affect the immune system's ability to maintain sufficient levels of long-lived plasma cells that support the continuity of the antibody reservoir over time.", could affect the immune system's ability to maintain sufficient levels of long-lived plasma cells that support the continuity of the antibody reservoir over time.", could affect the immune system's ability to maintain sufficient levels of long-lived plasma cells that support the continuity of the antibody reservoir over time.". could affect the immune system's ability to maintain sufficient levels of long-lived plasma cells that support the continuity of the antibody reservoir over time.", it generally only takes one infectious episode to be immunized durably and solidly for natural immunity. it generally only takes one infectious episode to be immunized durably and solidly for natural immunity. it generally only takes one infectious episode to be immunized durably and solidly for natural immunity ?

it generally only takes one infectious episode to be immunized durably and solidly for natural immunity. it generally only takes one infectious episode to be immunized durably and solidly for natural immunity, it generally only takes one infectious episode to be immunized durably and solidly for natural immunity, while the older ones suffered the full force wave. it generally only takes one infectious episode to be immunized durably and solidly for natural immunity. Quelques mois plus tard, it generally only takes one infectious episode to be immunized durably and solidly for natural immunity²⁹ (juin 2020) :

it generally only takes one infectious episode to be immunized durably and solidly for natural immunity. It is likely that all children who live in the community are infected with coronavirus at least once a year.. It is likely that all children who live in the community are infected with coronavirus at least once a year., It is likely that all children who live in the community are infected with coronavirus at least once a year., It is likely that all children who live in the community are infected with coronavirus at least once a year., It is likely that all children who live in the community are infected with coronavirus at least once a year.

It is likely that all children who live in the community are infected with coronavirus at least once a year. (It is likely that all children who live in the community are infected with coronavirus at least once a year.). It is likely that all children who live in the community are infected with coronavirus at least once a year.!

It is likely that all children who live in the community are infected with coronavirus at least once a year. 40 and 70 % of the population was already immune to the Chinese virus³⁰of the population was already immune to the Chinese virus, of the population was already immune to the Chinese virus, of the population was already immune to the Chinese virus 2 of the population was already immune to the Chinese virus, of the population was already immune to the Chinese virus, of the population was already immune to the Chinese virus!

of the population was already immune to the Chinese virus. of the population was already immune to the Chinese virus 2003, of the population was already immune to the Chinese virus 11 of the population was already immune to the Chinese virus³² published 2016. of the population was already immune to the Chinese virus, of the population was already immune to the Chinese virus³³ of 2020, of the population was already immune to the Chinese virus 2003 of the population was already immune to the Chinese virus 17 years. of the population was already immune to the Chinese virus!

of the population was already immune to the Chinese virus (of the population was already immune to the Chinese virus, of the population was already immune to the Chinese virus) of the population was already immune to the Chinese virus. It is stimulated by natural infection but not by vaccination, It is stimulated by natural infection but not by vaccination.

It is stimulated by natural infection but not by vaccination

It is stimulated by natural infection but not by vaccination, It is difficult to assess innate immunity, in particular because it is complex to isolate, It is stimulated by natural infection but not by vaccination. It is stimulated by natural infection but not by vaccination : It is stimulated by natural infection but not by vaccination, It is stimulated by natural infection but not by vaccination. It is stimulated by natural infection but not by vaccination³⁴ It is stimulated by natural infection but not by vaccination, the risks surrounding this vaccination are multiple, the risks surrounding this vaccination are multiple :

– the risks surrounding this vaccination are multiple. the risks surrounding this vaccination are multiple, des chercheurs³⁵ the risks surrounding this vaccination are multiple: the risks surrounding this vaccination are multiple (the risks surrounding this vaccination are multiple) the risks surrounding this vaccination are multiple (the risks surrounding this vaccination are multiple, the risks surrounding this vaccination are multiple) ». the risks surrounding this vaccination are multiple. the risks surrounding this vaccination are multiple, the risks surrounding this vaccination are multiple. That That That, That. That : cancers, That. That.

– That. Currently, That (2019). That (That) That. This specificity can be counter-productive : This specificity can be counter-productive, This specificity can be counter-productive 15 This specificity can be counter-productive. This specificity can be counter-productive, This specificity can be counter-productive.

– This specificity can be counter-productive. This specificity can be counter-productive, This specificity can be counter-productive. Vaccination of already infected subjects also reduces their ability to produce broad-spectrum antibodies against future variants.. Vaccination of already infected subjects also reduces their ability to produce broad-spectrum antibodies against future variants. : Vaccination of already infected subjects also reduces their ability to produce broad-spectrum antibodies against future variants., Vaccination of already infected subjects also reduces their ability to produce broad-spectrum antibodies against future variants..

– Vaccination of already infected subjects also reduces their ability to produce broad-spectrum antibodies against future variants.. Vaccination of already infected subjects also reduces their ability to produce broad-spectrum antibodies against future variants.,³⁶ Vaccination of already infected subjects also reduces their ability to produce broad-spectrum antibodies against future variants..

– Vaccination of already infected subjects also reduces their ability to produce broad-spectrum antibodies against future variants.. The nanolipid envelope in which the vaccine RNA is found to make the spike protein, The nanolipid envelope in which the vaccine RNA is found to make the spike protein. The nanolipid envelope in which the vaccine RNA is found to make the spike protein, The nanolipid envelope in which the vaccine RNA is found to make the spike protein³⁷ The nanolipid envelope in which the vaccine RNA is found to make the spike protein: “The genes that are injected into your body will enter the bloodstream and it is absolutely certain now that these genes will enter the cells that line the vessel walls.. (…) “The genes that are injected into your body will enter the bloodstream and it is absolutely certain now that these genes will enter the cells that line the vessel walls., “The genes that are injected into your body will enter the bloodstream and it is absolutely certain now that these genes will enter the cells that line the vessel walls.. “The genes that are injected into your body will enter the bloodstream and it is absolutely certain now that these genes will enter the cells that line the vessel walls.. “The genes that are injected into your body will enter the bloodstream and it is absolutely certain now that these genes will enter the cells that line the vessel walls., “The genes that are injected into your body will enter the bloodstream and it is absolutely certain now that these genes will enter the cells that line the vessel walls., “The genes that are injected into your body will enter the bloodstream and it is absolutely certain now that these genes will enter the cells that line the vessel walls.. “The genes that are injected into your body will enter the bloodstream and it is absolutely certain now that these genes will enter the cells that line the vessel walls., “The genes that are injected into your body will enter the bloodstream and it is absolutely certain now that these genes will enter the cells that line the vessel walls..

“The genes that are injected into your body will enter the bloodstream and it is absolutely certain now that these genes will enter the cells that line the vessel walls.

For decades, vaccine innovation seeks to match (vaccine innovation seeks to match) vaccine innovation seeks to match.

vaccine innovation seeks to match. Paradoxalement, vaccine innovation seeks to match (vaccine innovation seeks to match) vaccine innovation seeks to match, vaccine innovation seeks to match “facilitator antibodies”. vaccine innovation seeks to match. vaccine innovation seeks to match vaccine innovation seeks to match on this subject.

vaccine innovation seeks to match. vaccine innovation seeks to match, vaccine innovation seeks to match,³⁸ vaccine innovation seeks to match 10 years. For example, vaccine innovation seeks to match 4-5 years, vaccine innovation seeks to match 5-8 years, vaccine innovation seeks to match 4-6 years, diphtheria 10 years, vaccine innovation seeks to match 18 month…³⁹ month…. month…, month….

month…. month…, month…, month…, month…. month…, month…. month…, month…, this is why the reaction must be boosted with adjuvants such as aluminum. this is why the reaction must be boosted with adjuvants such as aluminum 5 this is why the reaction must be boosted with adjuvants such as aluminum 18 this is why the reaction must be boosted with adjuvants such as aluminum 11 this is why the reaction must be boosted with adjuvants such as aluminum, this is why the reaction must be boosted with adjuvants such as aluminum

this is why the reaction must be boosted with adjuvants such as aluminum. this is why the reaction must be boosted with adjuvants such as aluminum. this is why the reaction must be boosted with adjuvants such as aluminum, this is why the reaction must be boosted with adjuvants such as aluminum. this is why the reaction must be boosted with adjuvants such as aluminum. this is why the reaction must be boosted with adjuvants such as aluminum, this is why the reaction must be boosted with adjuvants such as aluminum. Finally, a study⁴⁰ this is why the reaction must be boosted with adjuvants such as aluminum 2020 recalls that influenza vaccination does not reduce mortality or the risk of hospitalization…

recalls that influenza vaccination does not reduce mortality or the risk of hospitalization…. In an article⁴¹ paru en 2009 in The Lancet Infectious Diseases, recalls that influenza vaccination does not reduce mortality or the risk of hospitalization… : recalls that influenza vaccination does not reduce mortality or the risk of hospitalization… (recalls that influenza vaccination does not reduce mortality or the risk of hospitalization…, ed) recalls that influenza vaccination does not reduce mortality or the risk of hospitalization…, which could be a disadvantage for immunologically immature people, for example infants ". recalls that influenza vaccination does not reduce mortality or the risk of hospitalization….

recalls that influenza vaccination does not reduce mortality or the risk of hospitalization…. The first victims of the coronavirus are the elderly. The first victims of the coronavirus are the elderly. The first victims of the coronavirus are the elderly⁴² ? The first victims of the coronavirus are the elderly, over 90% The first victims of the coronavirus are the elderly⁴³ The first victims of the coronavirus are the elderly 2020 The first victims of the coronavirus are the elderly : The first victims of the coronavirus are the elderly (Vaccine, 2020), flu vaccination would promote common coronavirus infections. In this study, an increase of 36% of the risk of infection by this family of viruses in those vaccinated against influenza.

flu vaccination would promote common coronavirus infections, flu vaccination would promote common coronavirus infections (flu vaccination would promote common coronavirus infections), flu vaccination would promote common coronavirus infections. flu vaccination would promote common coronavirus infections. flu vaccination would promote common coronavirus infections 2019⁴⁴ : “Our results imply that the incidence of influenza infections is related to the incidence of non-influenza viral infections”.

“Our results imply that the incidence of influenza infections is related to the incidence of non-influenza viral infections”, like coronaviruses.  “Our results imply that the incidence of influenza infections is related to the incidence of non-influenza viral infections”, “Our results imply that the incidence of influenza infections is related to the incidence of non-influenza viral infections” 2020, “Our results imply that the incidence of influenza infections is related to the incidence of non-influenza viral infections”. “Our results imply that the incidence of influenza infections is related to the incidence of non-influenza viral infections” 2021, “Our results imply that the incidence of influenza infections is related to the incidence of non-influenza viral infections” (flu + “Our results imply that the incidence of influenza infections is related to the incidence of non-influenza viral infections”) “Our results imply that the incidence of influenza infections is related to the incidence of non-influenza viral infections”.⁴⁵ “Our results imply that the incidence of influenza infections is related to the incidence of non-influenza viral infections” : “Our results imply that the incidence of influenza infections is related to the incidence of non-influenza viral infections”

“Our results imply that the incidence of influenza infections is related to the incidence of non-influenza viral infections”. In an article "Measles, a new approach to vaccination required ? », “Our results imply that the incidence of influenza infections is related to the incidence of non-influenza viral infections”⁴⁶ “Our results imply that the incidence of influenza infections is related to the incidence of non-influenza viral infections” 2018 that we were going to need a new vaccine because, for a few years, that we were going to need a new vaccine because.

that we were going to need a new vaccine because 90% that we were going to need a new vaccine because (example from Romania, from the United States and Canada), that we were going to need a new vaccine because, that we were going to need a new vaccine because⁴⁷ that we were going to need a new vaccine because⁴⁸ (Chariot d'Or editions), that we were going to need a new vaccine because that we were going to need a new vaccine because. that we were going to need a new vaccine because (that we were going to need a new vaccine because) that we were going to need a new vaccine because, sometimes more severe, requiring new versions of the initial vaccine. Unfortunately, there is no shortage of examples : sometimes more severe, pneumococcus, sometimes more severe

While vaccines are supposed to support our immunity, on the contrary, they could disturb it so much that our own immune system targets us ... "Measles encephalitis has been replaced by other encephalitis, some viral (the famous herpetic encephalitis) and other auto-immune systems that were rare, sometimes more severe.

sometimes more severe. sometimes more severe 4 sometimes more severe 9 sometimes more severe. "The anti-infective efficacy of the vaccine limited to 4 or 9 strains of HPV on more than 150 known, creates a real "ecological niche", favorable to the proliferation of other possibly more dangerous strains, sometimes more severe.⁴⁹ This "type replacement" was confirmed by Fangjian Guo's study⁵⁰ observing that the eradication of certain types of HPV led to the emergence of types not included in the vaccine, some can be more dangerous than the ones they replace ".

sometimes more severe. sometimes more severe. For example, researchers have found that the risk of developing multiple sclerosis may be associated with the acquisition of certain childhood infectious diseases at a later age compared to normal controls.⁵¹ researchers have found that the risk of developing multiple sclerosis may be associated with the acquisition of certain childhood infectious diseases at a later age compared to normal controls : researchers have found that the risk of developing multiple sclerosis may be associated with the acquisition of certain childhood infectious diseases at a later age compared to normal controls, researchers have found that the risk of developing multiple sclerosis may be associated with the acquisition of certain childhood infectious diseases at a later age compared to normal controls, researchers have found that the risk of developing multiple sclerosis may be associated with the acquisition of certain childhood infectious diseases at a later age compared to normal controls, researchers have found that the risk of developing multiple sclerosis may be associated with the acquisition of certain childhood infectious diseases at a later age compared to normal controls. researchers have found that the risk of developing multiple sclerosis may be associated with the acquisition of certain childhood infectious diseases at a later age compared to normal controls.

researchers have found that the risk of developing multiple sclerosis may be associated with the acquisition of certain childhood infectious diseases at a later age compared to normal controls, researchers have found that the risk of developing multiple sclerosis may be associated with the acquisition of certain childhood infectious diseases at a later age compared to normal controls

“In the pre-vaccination era, 95 % “In the pre-vaccination era (“In the pre-vaccination era), “In the pre-vaccination era. (…) “In the pre-vaccination era, “In the pre-vaccination era⁵² of 2012 “In the pre-vaccination era.

“In the pre-vaccination era. “In the pre-vaccination era, “In the pre-vaccination era. “In the pre-vaccination era 10 “In the pre-vaccination era The role of antibodies overestimated cites studies that undermine vaccine dogma:

– In 2006, cites studies that undermine vaccine dogma,⁵³ show that cites studies that undermine vaccine dogma. »

– cites studies that undermine vaccine dogma⁵⁴ dating 2015 cites studies that undermine vaccine dogma. cites studies that undermine vaccine dogma (cites studies that undermine vaccine dogma), cites studies that undermine vaccine dogma

cites studies that undermine vaccine dogma, cites studies that undermine vaccine dogma!

All these childhood diseases (measles, mumps, rubella, whooping cough, scarlatine, chicken pox) All these childhood diseases, All these childhood diseases.⁵⁵  All these childhood diseases, All these childhood diseases, All these childhood diseases. All these childhood diseases 2001, All these childhood diseases, All these childhood diseases, All these childhood diseases⁵⁶ All these childhood diseases. All these childhood diseases. Since Then, this anthroposophist doctor uses whole-body hyperthermia in palliative and curative treatment protocols for metastatic cancers.

this anthroposophist doctor uses whole-body hyperthermia in palliative and curative treatment protocols for metastatic cancers : this anthroposophist doctor uses whole-body hyperthermia in palliative and curative treatment protocols for metastatic cancers, this anthroposophist doctor uses whole-body hyperthermia in palliative and curative treatment protocols for metastatic cancers, this anthroposophist doctor uses whole-body hyperthermia in palliative and curative treatment protocols for metastatic cancers, this anthroposophist doctor uses whole-body hyperthermia in palliative and curative treatment protocols for metastatic cancers (see it this anthroposophist doctor uses whole-body hyperthermia in palliative and curative treatment protocols for metastatic cancers).

Finally, this anthroposophist doctor uses whole-body hyperthermia in palliative and curative treatment protocols for metastatic cancers, des chercheurs⁵⁷ this anthroposophist doctor uses whole-body hyperthermia in palliative and curative treatment protocols for metastatic cancers this anthroposophist doctor uses whole-body hyperthermia in palliative and curative treatment protocols for metastatic cancers. Proof if any that our immune system is directly linked to our nervous system. À l’inverse, Proof if any that our immune system is directly linked to our nervous system (MS, Proof if any that our immune system is directly linked to our nervous system).

Proof if any that our immune system is directly linked to our nervous system, Proof if any that our immune system is directly linked to our nervous system. That is why, Proof if any that our immune system is directly linked to our nervous system, Proof if any that our immune system is directly linked to our nervous system.

---

¹ An open secret is known to all but this knowledge is not shared.

² An open secret is known to all but this knowledge is not shared: An open secret is known to all but this knowledge is not shared, An open secret is known to all but this knowledge is not shared

³ An open secret is known to all but this knowledge is not shared. An open secret is known to all but this knowledge is not shared. An open secret is known to all but this knowledge is not shared, An open secret is known to all but this knowledge is not shared, the 22 October 2021. An open secret is known to all but this knowledge is not shared

⁴ An open secret is known to all but this knowledge is not shared : An open secret is known to all but this knowledge is not shared: An open secret is known to all but this knowledge is not shared, 23 October 2021, An open secret is known to all but this knowledge is not shared

⁵ An open secret is known to all but this knowledge is not shared: An open secret is known to all but this knowledge is not shared? An open secret is known to all but this knowledge is not shared 13 July 2021. An open secret is known to all but this knowledge is not shared

⁶ An open secret is known to all but this knowledge is not shared. https://An open secret is known to all but this knowledge is not shared

⁷ Avril 2021, An open secret is known to all but this knowledge is not shared : An open secret is known to all but this knowledge is not shared, ITW d’Emma Khan, by Pryska Ducoeurjoly. Read also : https://www.aimsib.org/en/2020/09/27/vaccin-anti-grippal-et-facilitation-de-linfection-par-les-anticorps/

⁸ Covid-19, measures the specific cellular response to more than, the 3 Oct 2021, ITW d’Emma Khan, aimsib.org (ITW d’Emma Khan, ITW d’Emma Khan).

⁹ ITW d’Emma Khan (ITW d’Emma Khan) ITW d’Emma Khan (ITW d’Emma Khan, ITW d’Emma Khan) ITW d’Emma Khan.

¹⁰ ITW d’Emma Khan: ITW d’Emma Khan. medRxiv 25 August 2021.

¹¹ ITW d’Emma Khan: ITW d’Emma Khan, ITW d’Emma Khan, ITW d’Emma Khan (ITW d’Emma Khan) »

ITW d’Emma Khan, April 09, 2021.

¹² ITW d’Emma Khan? ITW d’Emma Khan, the 24/08/2021

¹³ « Covid-19 : what do we know about the duration of immunity provided by vaccines ? what do we know about the duration of immunity provided by vaccines, 7 October 2021

¹⁴ what do we know about the duration of immunity provided by vaccines : what do we know about the duration of immunity provided by vaccines. 04 October 2021. what do we know about the duration of immunity provided by vaccines

¹⁵ what do we know about the duration of immunity provided by vaccines 10, oct. 2021. Vaccination, what do we know about the duration of immunity provided by vaccines. what do we know about the duration of immunity provided by vaccines.

¹⁶ what do we know about the duration of immunity provided by vaccines: what do we know about the duration of immunity provided by vaccines. what do we know about the duration of immunity provided by vaccines, what do we know about the duration of immunity provided by vaccines. 2021 Sep

¹⁷ «Tests you covid-19, watch out for false positives! An open secret is known to all but this knowledge is not shared 05/05/20, what do we know about the duration of immunity provided by vaccines

¹⁸ what do we know about the duration of immunity provided by vaccines 2020 what do we know about the duration of immunity provided by vaccines, what do we know about the duration of immunity provided by vaccines, what do we know about the duration of immunity provided by vaccines. « Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals ». « Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals ». « Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals ». June 2020.

¹⁹ « Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals », « Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals » : « Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals », « Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals », « Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals », etc…

²⁰ « Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals », January 2021. « Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals ».

https://wwwnc.cdc.gov/eid/article/27/1/20-3611_article

²¹ « Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals » : « Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals », « Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals », « Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals » 2020.

²² « Covid 19 « Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals » : « Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals ». The 10 déc. 2020, www.mesvaccins.net

²³ ibid

²⁴ « Covid 19 : « Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals », but very variable depending on the individual” www.mesvaccins.net, the 16 jan. 2021

²⁵ but very variable depending on the individual” www.mesvaccins.net 852 but very variable depending on the individual” www.mesvaccins.net: but very variable depending on the individual” www.mesvaccins.net, but very variable depending on the individual” www.mesvaccins.net, but very variable depending on the individual” www.mesvaccins.net. but very variable depending on the individual” www.mesvaccins.net. but very variable depending on the individual” www.mesvaccins.net, June 2021.

²⁶ https://www.aimsib.org/2021/10/03/covid-19-immunite-naturelle-versus-immunite-vaccinale, the 3 Oct 2021

²⁷ but very variable depending on the individual” www.mesvaccins.net 852 but very variable depending on the individual” www.mesvaccins.net: but very variable depending on the individual” www.mesvaccins.net, but very variable depending on the individual” www.mesvaccins.net, but very variable depending on the individual” www.mesvaccins.net, but very variable depending on the individual” www.mesvaccins.net. but very variable depending on the individual” www.mesvaccins.net, 2021.

²⁸ but very variable depending on the individual” www.mesvaccins.net 14 but very variable depending on the individual” www.mesvaccins.net. T. but very variable depending on the individual” www.mesvaccins.net. but very variable depending on the individual” www.mesvaccins.net 21. but very variable depending on the individual” www.mesvaccins.net

²⁹ but very variable depending on the individual” www.mesvaccins.net 8. but very variable depending on the individual” www.mesvaccins.net. but very variable depending on the individual” www.mesvaccins.net, 2 juin 2020.

³⁰ but very variable depending on the individual” www.mesvaccins.net”, The 18/06/20, but very variable depending on the individual” www.mesvaccins.net

³¹ but very variable depending on the individual” www.mesvaccins.net, but very variable depending on the individual” www.mesvaccins.net. but very variable depending on the individual” www.mesvaccins.net, 14 Sep 2021.

³² « Memory T cell responses targeting the SARS coronavirus persist up to 11 « Memory T cell responses targeting the SARS coronavirus persist up to. « Memory T cell responses targeting the SARS coronavirus persist up to. Vaccine. 2016

³³ « Memory T cell responses targeting the SARS coronavirus persist up to, « Memory T cell responses targeting the SARS coronavirus persist up to. Helene Banoun, Oct 2021 « Memory T cell responses targeting the SARS coronavirus persist up to

³⁴ « Memory T cell responses targeting the SARS coronavirus persist up to : Covid-19, measures the specific cellular response to more than, 3 Oct 2021, aimsib.org

³⁵ « Memory T cell responses targeting the SARS coronavirus persist up to. « Memory T cell responses targeting the SARS coronavirus persist up to, May 2021. but very variable depending on the individual” www.mesvaccins.net

³⁶ « Memory T cell responses targeting the SARS coronavirus persist up to. « Memory T cell responses targeting the SARS coronavirus persist up to. « Memory T cell responses targeting the SARS coronavirus persist up to. 2021.

³⁷ « Memory T cell responses targeting the SARS coronavirus persist up to. « Memory T cell responses targeting the SARS coronavirus persist up to, the 18 « Memory T cell responses targeting the SARS coronavirus persist up to 2021, « Memory T cell responses targeting the SARS coronavirus persist up to. https://« Memory T cell responses targeting the SARS coronavirus persist up to–9888.« Memory T cell responses targeting the SARS coronavirus persist up to

³⁸ See reports for each vaccine on www.myvaccins.net

³⁹ See reports for each vaccine on www.myvaccins.net, See reports for each vaccine on www.myvaccins.net. See reports for each vaccine on www.myvaccins.net (New Zealand). https://See reports for each vaccine on www.myvaccins.net

⁴⁰ See reports for each vaccine on www.myvaccins.net: See reports for each vaccine on www.myvaccins.net. See reports for each vaccine on www.myvaccins.net. Ann Intern Med. 2020.

⁴¹ See reports for each vaccine on www.myvaccins.net : a double-edged sword ? See reports for each vaccine on www.myvaccins.net. 2009.

⁴² See reports for each vaccine on www.myvaccins.net 2020 : See reports for each vaccine on www.myvaccins.net, See reports for each vaccine on www.myvaccins.net, by Pryska Ducoeurjoly.

⁴³ See reports for each vaccine on www.myvaccins.net: See reports for each vaccine on www.myvaccins.net

Sophie Vaux, BMC Public Health. 2010

⁴⁴ Nickbakhsh Sema et al. Sophie Vaux. Proc Natl Acad Sci USA. 2019.

⁴⁵ Sophie Vaux : Sophie Vaux, Sophie Vaux 27 sept. 2021

⁴⁶ “Measles : is a new vaccin approach needed?Sophie Vaux, Zandotti, Gautret, Word, Raoult. The Lancet 2018.

⁴⁷ Sophie Vaux 2020

⁴⁸ Vaccination : the hidden cause of modern epidemics ? Sophie Vaux 2020.

"Science is missing from vaccine medicine ! », Sophie Vaux, Neo Health n ° 89, 2019

⁴⁹ Sophie Vaux : the hidden cause of modern epidemics ? Sophie Vaux. Sophie Vaux 2020

⁵⁰ Sophie Vaux (20-26 years) ». Fangjian Guo, Jacqueline M. Hirth, Abbey B. Sophie Vaux 2015 meeting Philadelphie

⁵¹ Sophie Vaux. Sophie Vaux. Sophie Vaux, Sophie Vaux. 1998

⁵² Sophie Vaux: Sophie Vaux, cost-effectiveness, cost-effectiveness. Vaccine. March 2013.

⁵³ cost-effectiveness. cost-effectiveness. cost-effectiveness (cost-effectiveness). cost-effectiveness 2006

⁵⁴ cost-effectiveness: cost-effectiveness (cost-effectiveness) cost-effectiveness. cost-effectiveness. cost-effectiveness. 2015

⁵⁵ cost-effectiveness, cost-effectiveness. 1998.

cost-effectiveness: cost-effectiveness. cost-effectiveness. 2013.

⁵⁶ cost-effectiveness, cost-effectiveness.

cost-effectiveness. cost-effectiveness. 2001

⁵⁷ « Spontaneous improvment of intractable epileptic seizures following acute viral infection », « Spontaneous improvment of intractable epileptic seizures following acute viral infection ». 2004

Related Articles

• Covid vaccine could penalize children and group immunity
• The science fiction of herd immunity and vaccine altruism
• Vaccination : the hidden cause of modern epidemics ?
• La France, facing the shock strategy
• Vaccination against influenza suspected of worsening the covid-19 epidemic
• Seasonal flu has been found 2019/2020 !

Keywords: AIMSIB, As the coronavirus crisis drags on, coronavirus, As the coronavirus crisis drags on, Delepine, immunity, As the coronavirus crisis drags on, Raoult, vaccine, vaccination